The effect of rhBMP-2 in single-level posterior lumbar interbody arthrodesis .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
The effect of recombinant human bone morphogenetic protein-2 in single-level posterior lumbar interbody arthrodesis
J Bone Joint Surg Am. 2013 May 15;95(10):873-80. doi: 10.2106/JBJS.L.0013740 patients undergoing single-level posterior lumbar interbody arthrodesis were randomized to receive two polyetheretherketone cages filled with either recombinant human bone morphogenetic protein-2 (rhBMP-2) or an autologous iliac crest bone graft. The purpose of the study was to determine whether there were any differences in clinical and radiographic outcomes between the two groups of patients. Following 24 months of assessments, there were no significant differences in VAS pain, ODI, and SF-36 scores. However, bone density and trabecular bone formation were significantly lower in the rhBMP-2 group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
